Skip to content
HowShorted

Accelerate Diagnostics, Inc short interest in 2019

In 2019, Accelerate Diagnostics, Inc's disclosed short interest ran from 29.17% of shares outstanding on 15 Jan 2019 to 29.74% on 31 Dec 2019, a change of +0.57 percentage points. The year's high was 29.93% on 13 Dec 2019 and its low 24.65% on 29 Mar 2019, averaging 28.28% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 111.88 days on 31 Jul 2019. Full history: Accelerate Diagnostics, Inc.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025

Aggregate net short position time series for Accelerate Diagnostics, Inc in 2019

2019 in figures

Start of year
29.17% (15 Jan 2019)
End of year
29.74% (31 Dec 2019)
Change
+0.57 pp
High
29.93% (13 Dec 2019)
Low
24.65% (29 Mar 2019)
Average
28.28%
Highest days to cover
111.88 (31 Jul 2019)
SEC filings marked
9

Every report in 2019

Accelerate Diagnostics, Inc short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 201929.17%34.17results (8-K)
31 Jan 201929.04%28.59
15 Feb 201928.10%50.96
28 Feb 201926.59%37.01results (8-K)
15 Mar 201925.68%62.2010-K filed
29 Mar 201924.65%85.89
15 Apr 201925.33%57.41
30 Apr 201926.08%59.68
15 May 201927.62%60.99results (8-K), 10-Q filed
31 May 201928.51%87.76
14 Jun 201928.28%106.17
28 Jun 201928.40%77.47
15 Jul 201929.00%77.18
31 Jul 201928.76%111.88
15 Aug 201928.51%60.6610-Q filed, results (8-K)
30 Aug 201928.84%87.66
13 Sep 201929.30%82.50
30 Sep 201929.29%62.39
15 Oct 201929.05%62.18
31 Oct 201929.79%95.13
15 Nov 201929.29%78.09results (8-K), 10-Q filed
29 Nov 201929.81%85.63
13 Dec 201929.93%89.44
31 Dec 201929.74%105.93

See also: Accelerate Diagnostics, Inc's full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.